Analyst Note Rocks GE; Drug Stock Pops on FDA Nod

GE is trading just above its lows from earlier this month

Mar 13, 2018 at 1:53 PM
facebook X logo linkedin


Stocks have given back their early gains following the shake-up in President Trump's cabinet. Among individual names making notable moves are chipmaker Advanced Micro Devices, Inc. (NASDAQ:AMD), Dow component General Electric Company (NYSE:GE), and biotech Proteostasis Therapeutics Inc (NASDAQ:PTI). Here's a quick look at what's driving shares of AMD, GE, and PTI.

AMD Shares Ricochet Higher

AMD stock is in focus today after cybersecurity research firm CTS Labs published a report detailing multiple "severe security" flaws in the company's chips. However, as of last check the shares had pared earlier losses to trade up 1.5% at $11.70.

Advanced Micro Devices has been making big moves on the charts for months, and recently saw a boom in put trading. One indicator that stands out is AMD's Schaeffer's put/call open interest ratio (SOIR) of 1.40. Not only does this show put open interest outweighing call open interest among contracts expiring within three months, but it ranks just 2 percentage points from a 12-month high.

Bear Note Sinks GE Stock Again

General Electric shares are trading down 4.1% at $14.48 -- not far from their March 1 low of $13.95 -- after a price-target cut to $11 from $14 at J.P. Morgan Securities. The brokerage firm, which rates the stock at "underweight," said GE's dividend is "still high risk." The blue-chip stock has shed more than half its value over the past year.

Elsewhere, short interest has been tick-tocking higher since early 2017 -- yet less than 2% of the equity's float is sold short. This suggests there's plenty of room for short sellers to pile on.

Proteostasis Therapeutics Stock Jumps 53%

Proteostasis Therapeutics announced the Food and Drug Administration (FDA) has granted a breakthrough therapy designation to its cystic fibrosis drug. Shares of PTI were last seen up 53.2% at $6.34, making it the second best stock on the Nasdaq today. This move has the stock on pace for its highest close in almost a year, as the $6.40 level kept a tight lid on the last breakout attempt in December and January. Analysts certainly have high expectations, given Proteostasis' average 12-month price target of $14.75.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI